Apollo Sugar Clinic inks deal with Israel’s GlucoMe\'s Digital Diabetes Care Solution for Diabetes Home-Care Program in India

2018-01-07 02:15:06

Apollo Hospitals Group\'s nationwide chain of diabetes clinics in India has begun integrating the GlucoMe digital diabetes care solution into its recently launched national diabetes home-care program.By Team ABLEDigital diabetes platform provider GlucoMe has announced that Apollo Sugar, Apollo Hospitals Group\'s nationwide chain of diabetes clinics in India, has begun integrating the GlucoMe digit

Read more

Health Ministry, Tata Memorial Centre launch first Digital Online Oncology Tutorial

2018-01-07 02:13:46

This is part of a national program that will be rolled out across the country by Tata Memorial Centre in collaboration with state governments.By Team ABLEPreeti Sudan, Secretary (HFW) has launched the country’s first digital Online Oncology Tutorial Series designed by the Tata Memorial Center in collaboration with the Health Ministry. The oncology tutorial series aim to train the doctors across

Read more

Infosys partners with ValGenesis to further enable digitization in Life Sciences

2018-01-07 02:11:17

Under the partnership, Infosys will integrate ValGenesis’ Validation Lifecycle Management System (VLMS) within its suite of services for the pharmaceutical and biotech industry.By Team ABLETech giant Infosys  has entered into a new partnership with London-based paperless validation company ValGenesis, which is expected to bring even stronger compliance and quality management for its custome

Read more

DBT announces Khorana Program for Scholars

2018-01-07 02:09:59

The Khorana Program will provide opportunities to Indian students to undertake research at University of Wisconsin-Madison (UW)By Team ABLEThe Department of Biotechnology (DBT), Govt. of India, Indo-US Science and Technology Forum (IUSSTF) and WINStep Forward are partnering to support the prestigious Khorana Program for Scholars named in honor of Dr. Har Gobind Khorana, who won the Nobel Prize in

Read more

Microsoft, Google support DNAnexus with $58 million investment to accelerate expansion

2018-01-04 10:03:40

Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical dataBy Team ABLEUS-based biomedical informatics and data management company DNAnexus has announced closing a $58 million financing led by new investor Foresite Capital with strategic investment from Microsoft. Existing inves

Read more

US FDA Commissioner Scott Gottlieb releases statement on new steps to facilitate efficient generic drug review

2018-01-04 10:00:25

FDA expects to take additional steps this year to promote competition; to help reduce drug prices and improve access to medicine for Americans.By Team ABLEThe FDA has announced, on Jan 3, 2018, additional steps to encourage generic competition as part of its continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that

Read more

Hetero launches AbbVie’s Humira biosimilar Adalimumab

2018-01-04 09:52:11

Mabura is an anti-inflammatory biologic medication specific for human tumor necrosis factor (TNF), indicated for the treatment of rheumatoid arthritis and other auto-immune disorders By Team ABLEHyderabad-based generic pharmaceutical company, Hetero Labs Ltd has announced on Jan 3, 2018 that it has launched its fourth biosimilar drug ‘Adalimumab’ under the brand name ‘Mabura’ in India. Het

Read more

Bharat Biotech’s typhoid vaccine Typbar gets WHO pre-qualification

2018-01-03 20:23:58

The $1.5 per dose ( Rs 100) is a game changer and is used in Pakistan. Global orders may get it at subsidized rates By Team ABLEIn a another major achievement, Typbar TCV, the typhoid conjugate vaccine from Krishna Ella-led Bharat Biotech has received prequalification approval from the World Health Organization (WHO) paving the way for large scale purchases by international agencies.Typbar TCV®&n

Read more

FDA approves Mylan’s generic for Estrace vaginal cream

2018-01-03 20:09:39

The US drug regulator has approved the first generic version of Allergan’s vaginal cream, Estrace, developed by Mylan on December 29,2017. Mylan received the final approval for its Abbreviated New Drug Application (ANDA) from the Food and Drug Administration(FDA) last week for its generic version, Estradiol Vaginal Cream.The innovator drug, Estrace of Allergan, had annual sales of about $387 mil

Read more

BiondVax Universal Flu Vaccine patent granted in India

2018-01-03 20:00:26

BiondVax Pharmaceuticals patents’ titled, ‘A Synthetic or Recombinant Influenza Multi-Epitope Polypeptide’ has been granted in India. By Team ABLEBiondVax Pharmaceuticals, Nasdaq-listed developer of M-001, the Universal Flu Vaccine candidate currently in preparation for a Phase 3 clinical trial, announced that one of its key patents titled, ‘A Synthetic or Recombinant Influenza Multi-Epito

Read more